Malaria's severity reset by mosquito

May 30, 2013
Mosquito transmission of P.c. chabaudi modifies parasite gene expression in the blood stage of the cycle.

(Medical Xpress)—For the first time, researchers have proven that the way in which malaria is transmitted to the host affects how severe the resulting infection will be.

The route of infection modifies the 's gene activity levels and regulates the parasite's spread in the blood by controlling the mouse's . This study begins to understand how to malaria occurs, an important step for the development of effective vaccines.

Researchers have known that the severity of symptoms of malaria increases when the malaria parasite is transferred repeatedly through in mice rather than by a mosquito, but up until now they have not known why.

"Understanding how malaria becomes more or less virulent is central to understanding how to manage and treat the disease," says Dr Matt Berriman, a senior author from the Wellcome Trust Sanger Institute. "We studied a rodent malaria species, that exhibits many of the same responses as seen in a human . Our understanding of how the parasite interacts with the immune system is fundamentally changed by this study."

To explore the effect that the route of transmission had, the team examined the levels of in the malaria parasite during its life cycle in mice.

They found that P.c. chabaudi 'resets' its when it is transmitted between the mosquito and mouse, making it less virulent. However, transferring the parasite through multiple blood transfers between mice in the laboratory loses this resetting. Because there is no reset the malaria parasite multiples much more quickly in mice after blood transfers, and causes an increase in .

The team uncovered a direct association between a specific gene family in the malaria parasite, known as cir genes, and the control of severity of the disease symptoms in mice. It appears that malaria parasite genes control the immune response of mice to the disease.

"Our research is helping to better understand vaccine targets," says Dr Adam Reid, author from the Wellcome Trust Sanger Institute. "RNA sequencing allowed us to identify a set of Plasmodium genes that control the immune response and the degree of severity of the disease in mice. We anticipate that we will be able to transfer the findings from our study in mice to human malaria studies, the next phase of our research."

The team expect that the cir gene family plays a role in activating the immune system and controls the level of parasite in the blood to keep malaria from harming the host. This is the largest in malaria parasites, including the deadly human parasite, P. falciparum.

The study was led by Dr Jean Langhorne based at the Medical Research Council National Institute for Medical Research: "These results place the mosquito at the centre of our efforts to pick apart the processes behind protective immunity to malaria. Malaria is both preventable and curable but still has a huge burden on those who are vulnerable to severe forms of the infection, mostly young children. Understanding protective immunity in the body would be an important first step towards developing an effective vaccine."

Explore further: No idle chatter: Study finds malaria parasites 'talk' to each other

More information: Spence, P. et al. Vector transmission regulates immune control of Plasmodium virulence, Nature 2013. DOI: 10.1038/nature12231

Related Stories

No idle chatter: Study finds malaria parasites 'talk' to each other

May 15, 2013
Melbourne scientists have made the surprise discovery that malaria parasites can 'talk' to each other – a social behaviour to ensure the parasite's survival and improve its chances of being transmitted to other humans.

Improving human immunity to malaria

August 1, 2012
The deadliest form of malaria is caused the protozoan Plasmodium falciparum. During its life-cycle in human blood, the parasite P. falciparum expresses unique proteins on the surface on infected blood cells.

Malaria parasite protein identified as potential new target for drug treatment

April 25, 2013
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments ...

Recommended for you

Study finds walnuts may promote health by changing gut bacteria

July 28, 2017
Research led by Lauri Byerley, PhD, RD, Research Associate Professor of Physiology at LSU Health New Orleans School of Medicine, has found that walnuts in the diet change the makeup of bacteria in the gut, which suggests ...

Green tea ingredient may ameliorate memory impairment, brain insulin resistance, and obesity

July 28, 2017
A study published online in The FASEB Journal, involving mice, suggests that EGCG (epigallocatechin-3-gallate), the most abundant catechin and biologically active component in green tea, could alleviate high-fat and high-fructose ...

Manipulating a type of brain cell gets weight loss results in mice

July 28, 2017
A new study has found something remarkable: the activation of a particular type of immune cell in the brain can, on its own, lead to obesity in mice. This striking result provides the strongest demonstration yet that brain ...

Team finds link between backup immune defense, mutation seen in Crohn's disease

July 27, 2017
Genes that regulate a cellular recycling system called autophagy are commonly mutated in Crohn's disease patients, though the link between biological housekeeping and inflammatory bowel disease remained a mystery. Now, researchers ...

Study finds harmful protein on acid triggers a life-threatening disease

July 27, 2017
Using an array of modern biochemical and structural biology techniques, researchers from Boston University School of Medicine (BUSM) have begun to unravel the mystery of how acidity influences a small protein called serum ...

CRISPR sheds light on rare pediatric bone marrow failure syndrome

July 27, 2017
Using the gene editing technology CRISPR, scientists have shed light on a rare, sometimes fatal syndrome that causes children to gradually lose the ability to manufacture vital blood cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.